Cryo-Cell International, Inc.
CCEL
$7.17
$0.14262.03%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.02M | 8.07M | 8.04M | 7.85M | 7.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.02M | 8.07M | 8.04M | 7.85M | 7.88M |
| Cost of Revenue | 1.64M | 2.13M | 2.02M | 2.16M | 5.76M |
| Gross Profit | 6.39M | 5.94M | 6.02M | 5.69M | 2.12M |
| SG&A Expenses | 6.01M | 4.15M | 4.02M | 4.34M | 5.44M |
| Depreciation & Amortization | 196.00K | 194.60K | 59.80K | 33.20K | 281.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.15M | 6.66M | 6.35M | 7.04M | 11.93M |
| Operating Income | -123.40K | 1.40M | 1.70M | 816.00K | -4.05M |
| Income Before Tax | -842.40K | 1.38M | 1.47M | 794.50K | -15.99M |
| Income Tax Expenses | 1.02M | 328.20K | 816.40K | 238.30K | -4.80M |
| Earnings from Continuing Operations | -1.86M | 1.05M | 655.80K | 556.20K | -11.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.86M | 1.05M | 655.80K | 556.20K | -11.19M |
| EBIT | -123.40K | 1.40M | 1.70M | 816.00K | -4.05M |
| EBITDA | 125.60K | 1.65M | 1.81M | 902.10K | -3.72M |
| EPS Basic | -0.23 | 0.13 | 0.08 | 0.07 | -1.35 |
| Normalized Basic EPS | -0.07 | 0.07 | 0.12 | 0.04 | -0.29 |
| EPS Diluted | -0.23 | 0.13 | 0.08 | 0.07 | -1.35 |
| Normalized Diluted EPS | -0.07 | 0.07 | 0.12 | 0.04 | -0.29 |
| Average Basic Shares Outstanding | 8.07M | 8.06M | 8.12M | 8.28M | 8.29M |
| Average Diluted Shares Outstanding | 8.07M | 8.17M | 8.23M | 8.33M | 8.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -108.54% | -- | -- | -- | -- |
